MULTIFACTORIAL ANALYSIS OF IMMUNE AND ENDOCRINE MARKERS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Keywords:
Polycystic ovary syndrome, AMH, cytokines, insulin resistance, inflammation, biomarkersAbstract
Background: Polycystic ovary syndrome (PCOS) is a multifactorial disorder associated with endocrine, metabolic, and immune dysregulation.
References
Azziz, R., Carmina, E., Chen, Z. et al. Polycystic ovary syndrome. //Nature Reviews | Disease Primers, 16057 (2016). - Vol.2 -Р. 1-18.
Banerjee S., Chakraborty P., Ghosh S. et al. Chronic low-grade inflammation in PCOS: Role in metabolic and reproductive disorders // Metabolism. — 2023. — Vol. 144. — P. 155603.
Dewailly D., Gronier H., Poncelet E. et al. Diagnostic value of AMH for PCOS // Front Horm Res. — 2020. — Vol. 53. — P. 71–82.
Di Pietro M., Filardo S., De Santis F. et al. SHBG and androgen availability in PCOS: a new insight // Endocr Rev. — 2022. — Vol. 43, No. 2. — P. 254–268.
Franks S., Stark J., Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome // Nat Rev Endocrinol. — 2021. — Vol. 17. — P. 193–206.
González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction // Fertility and Sterility. — 2019. — Vol. 111, No. 4. — P. 667–677.
Kuang H., Lin Q., Zhang Y. et al. The role of Th17 cells in polycystic ovary syndrome // Reprod Biol Endocrinol. — 2020. — Vol. 18. — P. 34.
Legro R.S., Arslanian S.A., Ehrmann D.A. et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline // N Engl J Med. — 2019. — Vol. 371. — P. 554–563.
Mazloomi S., Mazloomzadeh S., Kazemnejad E. et al. The role of cytokines in the pathogenesis of polycystic ovary syndrome: a cross-sectional study // J Reprod Immunol. — 2023. — Vol. 155. — P. 103792.
